Bowel Preparation Before Colonoscopy Clinical Trial
Official title:
Improved Bowel Cleansing Method for Colonoscopy Based on High Risk Population of Bowel Preparation#a Single-center,Endoscopist-blinded Randomized Controlled Trial
The purpose of this study is to observe the difference in bowel preparation quality between compound sodium picosulfate#CSP combined with lactulose and polyethylene glycol electrolyte#PEG combined with lactulose in high-risk population.
| Status | Recruiting |
| Enrollment | 150 |
| Est. completion date | June 30, 2023 |
| Est. primary completion date | June 30, 2023 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria:Adults undergoing colonoscopy who have at least one risk factor: age>70, previous colon surgery, constipation, diabetes, Parkinson's disease, history of stroke or spinal cord injury, prior history of inadequate bowel preparation, body mass index (BMI) >25, use of tricyclic antidepressant or narcotics. Exclusion Criteria: 1. presence of any contraindications for colonoscopy (gastrointestinal obstruction or perforation,severe acute inflammatory bowel disease,toxic megacolon,severe heart failure,unable to swallow,severe heart failure,etc); 2. Patients with galactosemia; 3. hypersensitivity to any of the ingredients; 4. Pregnancy or lactation; 5. Use of lactulose,prokinetic agents or purgatives within 7 days; 6. Unwilling to sign informed consent. |
| Country | Name | City | State |
|---|---|---|---|
| China | Renmin Hospital of Wuhan University | Wuhan | Hubei |
| Lead Sponsor | Collaborator |
|---|---|
| Renmin Hospital of Wuhan University |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Boston Bowel Preparation Scale | Cleanliness of the colon during colonoscopy will be evaluated by the Boston Bowel Preparation Scale which is a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. The total BBPS score ranged from 0 to 9. If total BostonBowel Preparation Score =6 with each segmental BBPS=2, we regard it as adequate bowel preparation. | during colonoscopy | |
| Secondary | Adenoma Detection Rate | Diagnosis was confirmed by histologic examination | 2 days | |
| Secondary | Polyp Detection Rate | Diagnosis was confirmed by histologic examination | 2 days | |
| Secondary | Rate of adverse events | adverse events, such as vomiting, nausea, headache, abdominal distention, abdominal pain. | 2 days | |
| Secondary | Cecal intubation rate | Colonoscopy reaches cecal region. | during colonoscopy | |
| Secondary | Cecal intubation time | Colonoscopy reaches cecal region. | during colonoscopy | |
| Secondary | Withdrawal time | The time from the cecum to the anus, but excluded time for biopsy performance or removal of polyps. | during colonoscopy | |
| Secondary | defecation frequency | Frequency of bowel movement. | 2 days | |
| Secondary | patient satisfaction Assessment | Patients' satisfaction score for bowel preparation (3 points: completely tolerable and very satisfied; 2 points: nausea and other discomfort, but still tolerable and satisfactory; 1: unable to tolerate, not satisfied);
And whether the patient is willing to use the bowel cleansing program for colonoscopy; |
2 days |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01984008 -
A Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy
|
Phase 3 | |
| Completed |
NCT01745835 -
Comparison Between 2L Coolprep® and Combination of 1L Coolprep® and Bisacodyl as Bowel Preparation
|
Phase 3 | |
| Completed |
NCT02910440 -
A Safety and Efficacy Study of DCL-101 Compared to GoLYTELY
|
Phase 2 | |
| Recruiting |
NCT05054036 -
MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy
|
Phase 4 | |
| Completed |
NCT04582942 -
Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification
|
N/A | |
| Recruiting |
NCT03106922 -
A Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children
|
Phase 3 |